3034 Stock Overview
Engages in management of dispensing pharmacies and business process outsourcing contracting businesses in Japan.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Qol Holdings Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,445.00 |
52 Week High | JP¥1,989.00 |
52 Week Low | JP¥1,396.00 |
Beta | 0.060 |
11 Month Change | -2.10% |
3 Month Change | -20.60% |
1 Year Change | -18.55% |
33 Year Change | -4.37% |
5 Year Change | -11.02% |
Change since IPO | 312.27% |
Recent News & Updates
There May Be Some Bright Spots In Qol Holdings' (TSE:3034) Earnings
May 21Qol Holdings Co., Ltd.'s (TSE:3034) Shares Not Telling The Full Story
May 13Shareholder Returns
3034 | JP Consumer Retailing | JP Market | |
---|---|---|---|
7D | 3.1% | -1.8% | -0.8% |
1Y | -18.5% | 4.1% | 16.3% |
Return vs Industry: 3034 underperformed the JP Consumer Retailing industry which returned 4.1% over the past year.
Return vs Market: 3034 underperformed the JP Market which returned 16.3% over the past year.
Price Volatility
3034 volatility | |
---|---|
3034 Average Weekly Movement | 5.7% |
Consumer Retailing Industry Average Movement | 3.3% |
Market Average Movement | 4.0% |
10% most volatile stocks in JP Market | 7.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 3034's share price has been volatile over the past 3 months.
Volatility Over Time: 3034's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 5,746 | Takashi Nakamura | www.qolhd.co.jp |
Qol Holdings Co., Ltd., together with its subsidiaries, engages in management of dispensing pharmacies and business process outsourcing contracting businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also undertakes sales and marketing research activities for pharmaceutical companies; and provides temporary staff dispatch for pharmacists, nurses, registered sellers, registered dietitians, etc. In addition, the company offers clinical trial support services for pharmaceuticals and food products; support, monitoring, and technician dispatch services of managers for various processes, from planning of trial execution plans to monitoring, secretariat support, statistical analysis, and the presentation of conference papers; and publishes books and magazines for medical professionals and patients.
Qol Holdings Co., Ltd. Fundamentals Summary
3034 fundamental statistics | |
---|---|
Market cap | JP¥54.19b |
Earnings (TTM) | JP¥4.88b |
Revenue (TTM) | JP¥180.05b |
11.1x
P/E Ratio0.3x
P/S RatioIs 3034 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3034 income statement (TTM) | |
---|---|
Revenue | JP¥180.05b |
Cost of Revenue | JP¥156.80b |
Gross Profit | JP¥23.25b |
Other Expenses | JP¥18.37b |
Earnings | JP¥4.88b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 130.75 |
Gross Margin | 12.91% |
Net Profit Margin | 2.71% |
Debt/Equity Ratio | 59.9% |
How did 3034 perform over the long term?
See historical performance and comparison